1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific OTC Drug and Dietary Supplement Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific OTC Drug and Dietary Supplement Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific OTC Drug and Dietary Supplement Market Regional Analysis
6.2 Asia Pacific OTC Drug and Dietary Supplement Market Revenue 2017-2027 (US$ Million)
6.3 Asia Pacific OTC Drug and Dietary Supplement Market Forecast Analysis
7. Asia Pacific OTC Drug and Dietary Supplement Market Analysis – by Product
7.1 Cough and Cold Products
- 7.1.1 Overview
- 7.1.2 Cough and Cold Products: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Vitamins and Dietary Supplements
- 7.2.1 Overview
- 7.2.2 Vitamins and Dietary Supplements: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Analgesics
- 7.3.1 Overview
- 7.3.2 Analgesics: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Gastrointestinal Products
- 7.4.1 Overview
- 7.4.2 Gastrointestinal Products: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Sleep Aids
- 7.5.1 Overview
- 7.5.2 Sleep Aids: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.6 Oral Care Products
- 7.6.1 Overview
- 7.6.2 Oral Care Products: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.7 Ophthalmic Products
- 7.7.1 Overview
- 7.7.2 Ophthalmic Products: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.8 Antacids
- 7.8.1 Overview
- 7.8.2 Antacids: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.9 Feminine Care
- 7.9.1 Overview
- 7.9.2 Feminine Care: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Asia Pacific OTC Drug and Dietary Supplement Market Analysis – by Type
8.1 Branded
- 8.1.1 Overview
- 8.1.2 Branded: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Generic
- 8.2.1 Overview
- 8.2.2 Generic: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Asia Pacific OTC Drug and Dietary Supplement Market Analysis – by Form
9.1 Tablets
- 9.1.1 Overview
- 9.1.2 Tablets: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Capsules
- 9.2.1 Overview
- 9.2.2 Capsules: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Powders
- 9.3.1 Overview
- 9.3.2 Powders: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.4 Ointments
- 9.4.1 Overview
- 9.4.2 Ointments: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.5 Liquid
- 9.5.1 Overview
- 9.5.2 Liquid: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. Asia Pacific OTC Drug and Dietary Supplement Market Analysis – by Distribution Channel
10.1 Hospital and Retail Pharmacies
- 10.1.1 Overview
- 10.1.2 Hospital and Retail Pharmacies: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
10.2 Retail Stores
- 10.2.1 Overview
- 10.2.2 Retail Stores: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
10.3 Online Channels
- 10.3.1 Overview
- 10.3.2 Online Channels: Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast, 2017-2027 (US$ Million)
11. Asia Pacific OTC Drug and Dietary Supplement Market – Asia-Pacific Analysis
11.1 Overview
11.2 Asia-Pacific
- 11.2.1 Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 11.2.1.1 Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 China:
Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.1.1 China: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Product
- 11.2.1.1.2 China: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Type
- 11.2.1.1.3 China: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Form
- 11.2.1.1.4 China: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Distribution Channel
- 11.2.1.2 India:
Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.2.1 India: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Product
- 11.2.1.2.2 India: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Type
- 11.2.1.2.3 India: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Form
- 11.2.1.2.4 India: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Distribution Channel
- 11.2.1.3 Japan:
Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.3.1 Japan: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Product
- 11.2.1.3.2 Japan: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Type
- 11.2.1.3.3 Japan: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Form
- 11.2.1.3.4 Japan: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Distribution Channel
- 11.2.1.4 Australia:
Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.4.1 Australia: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Product
- 11.2.1.4.2 Australia: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Type
- 11.2.1.4.3 Australia: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Form
- 11.2.1.4.4 Australia: Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Distribution Channel
- 11.2.1.5 Rest of Asia-Pacific :
Asia Pacific OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Product
- 11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Type
- 11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Form
- 11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific OTC Drug and Dietary Supplement Market Breakdown, by Distribution Channel
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 GlaxoSmithKline plc.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Sanofi
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Johnson and Johnson Services, Inc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Abbott
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 AbbVie Inc.
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Bausch Health Companies Inc.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Bayer AG
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Procter & Gamble
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Novartis AG
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Reckitt Benckiser Group Plc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Get Free Sample For Asia Pacific OTC Drug and Dietary Supplement Market
